Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients

Intensive Care Medicine

Volumn 29, Issue 11, 2003, Pages 1916-1920

  Ethuin, Frédéric ^a   Boudaoud, Said ^a   Leblanc, Isabelle ^a   Troje, Christian ^a   Marie, Olivier ^a   Levron, Jean Claude ^b   Le Moing, Jean Pierre ^b   Assoune, Patrice ^b   Eurin, Benoit ^a   Jacob, Laurent ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Centre de Recherche   (France)

Author keywords

Intensive care; Pharmacokinetics; Sedation; Sufentanil

Indexed keywords

MIDAZOLAM; SUFENTANIL;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HALF LIFE TIME; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER FAILURE; MALE; RADIOIMMUNOASSAY; SEDATION;

ADULT; AGED; ANALGESICS, OPIOID; APACHE; CONSCIOUS SEDATION; CRITICAL CARE; DRUG MONITORING; DRUG THERAPY, COMBINATION; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LONG-TERM CARE; MALE; METABOLIC CLEARANCE RATE; MIDAZOLAM; MIDDLE AGED; RADIOIMMUNOASSAY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SUFENTANIL; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 10744227492     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1920-y     Document Type: Article

References (23)

1. Shafer A (1998) Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 26:947-956
2. Soliman HM, Mélot C, Vincent J-L (2001) Sedative and analgesic pratice in the intensive care unit: the results of a European survey. Br J Anaesth 87:186-192
3. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, Schein RM, Spevetz A, Stone JR (1995) Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 23:1596-1600
4. Gepts E, Shafer SL, Camu F, Stanski DR, Woestenborghs R, Van Peer A, Heykants JJP (1995) Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 83:1194-1204
5. Bovill JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJ (1984) The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 61:502-506
6. Hudson RJ, Bergstrom RG, Thomson IR, Sabourin MA, Rosenbloom M, Strunin L (1989) Pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery. Anesthesiology 70:426-431
7. Lehman KA, Sipakis K, Gasparini R, Van Peer A (1993) Pharmacokinetics of sufentanil in general surgical patients under different conditions of anesthesia. Acta Anaesthesiol Scand 37:176-180
8. Hofbauer R, Tesinsky P, Hammerschmidt V (1999) No reduction in the sufentanil requirement of elderly patients undergoing ventilatory support in the medical intensive care unit. Eur J Anaesthesiol 16:702-707
9. Wappler F, Scholz J, Prause A (1998) Level concept of analgesic dosing in intensive care medicine with sufentanil. Anasthesiol Intensivmed Notfallmed Schmerzher 33:8-26
10. Le Gall J-R, Lenischow S, Saulnier F (1993) New simplified acute physiology score (SAPS II) based on European North American multicenter study. JAMA 270:2957-2963
11. Ramsay MAE, Savege TM, Simpson BJR, Goodwin R (1974) Controlled sedation with alphaxalone/alphadolone. BMJ 2:656-659
12. Michiels M, Hendrix R, Heykants JJ (1983) Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetics profile in man. J Pharm Pharmacol 35:86-93
13. Veng-Pedersen P (1989) Mean time parameters'in pharmacokinetics. Definition, computation and clinical implications. Clin Pharmacokinet 17:345-366
14. Chauvin M, Ferrier C, Haberer J-P, Spielvogel C, Levron J-C, Duvaldestin P (1989) Sufentanil pharmacokinetics in patients with cirrhosis. Anesth Analg 68:1-4
15. Brusset A, Levron J-C, Olivier P, Schlumberger S, Le Moing J-P, Dubois C, Guilmet D, Valide L, Guenoun T, Fischler M (1999) Comparative pharmacokinetic study of fentanyl and sufentanil after single high-bolus doses. Clin Drug Invest 18:377-389
16. Hughes MA, Glass PSA, Jacobs JR (1992) Context-sensitive half-life in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76:334-341
17. Kapila A, Glass PSA, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 8:968-975
18. Shafer SL, Varvel JR (1991) Pharmacokinetics, pharmacodynamics and rational opioid selection. Anesthesiology 74:53-63
19. Schraag S, Mohl U, Hirsch M, Stolberg E, Georgieff M (1998) Recovery from opioid anesthesia: the clinical implication of context-sensitive half-times. Anesth Analg 86:184-190
20. Shafer A, Doze VA, White PF (1990) Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med 18:1039-1041
21. Kapila A, Glass PSA, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL (1995) Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968-975
22. Chinachoti T, Kessler P, Kirkham A, Werawatganon T (2002) Remifentanil vs morphine for patients in intensive care unit who need short-term mechanical ventilation. J Med Assoc Thai 85:S848-S857
23. Soltész A, Biedler A, Silomon M, Schöpflin I, Molter GP (2001) Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery. Br J Anaesth 86:763-768